hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)e4
JournalThe Oncologist
Volume21
Issue number12
DOIs
Publication statusPublished - Dec 2016

Cite this

@article{7882c42f8eb94538a9ee381c166a0a44,
title = "hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients",
author = "Meijer, {Laura L} and Puik, {Jisce R} and Peters, {Godefridus J} and Geert Kazemier and Elisa Giovannetti",
year = "2016",
month = "12",
doi = "10.1634/theoncologist.2016-0262",
language = "English",
volume = "21",
pages = "e4",
journal = "The Oncologist",
issn = "1083-7159",
publisher = "AlphaMed Press",
number = "12",

}

hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients. / Meijer, Laura L; Puik, Jisce R; Peters, Godefridus J; Kazemier, Geert; Giovannetti, Elisa.

In: The Oncologist, Vol. 21, No. 12, 12.2016, p. e4.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - hENT-1 Expression and Localization Predict Outcome After Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients

AU - Meijer, Laura L

AU - Puik, Jisce R

AU - Peters, Godefridus J

AU - Kazemier, Geert

AU - Giovannetti, Elisa

PY - 2016/12

Y1 - 2016/12

U2 - 10.1634/theoncologist.2016-0262

DO - 10.1634/theoncologist.2016-0262

M3 - Article

VL - 21

SP - e4

JO - The Oncologist

JF - The Oncologist

SN - 1083-7159

IS - 12

ER -